These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 4009236)

  • 1. Cholecystokinin-induced excitation in the substantia nigra: evidence for peripheral and central components.
    Hommer DW; Palkovits M; Crawley JN; Paul SM; Skirboll LR
    J Neurosci; 1985 Jun; 5(6):1387-92. PubMed ID: 4009236
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Central and peripheral vagal transport of cholecystokinin binding sites occurs in afferent fibers.
    Moran TH; Norgren R; Crosby RJ; McHugh PR
    Brain Res; 1990 Aug; 526(1):95-102. PubMed ID: 2078822
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vagal afferent and efferent contributions to the inhibition of food intake by cholecystokinin.
    Moran TH; Baldessarini AR; Salorio CF; Lowery T; Schwartz GJ
    Am J Physiol; 1997 Apr; 272(4 Pt 2):R1245-51. PubMed ID: 9140026
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Abdominal vagal mediation of the satiety effects of exogenous and endogenous cholecystokinin in rats.
    Reidelberger RD
    Am J Physiol; 1992 Dec; 263(6 Pt 2):R1354-8. PubMed ID: 1481948
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vagal mediation of the cholecystokinin satiety effect in rats.
    Lorenz DN; Goldman SA
    Physiol Behav; 1982 Oct; 29(4):599-604. PubMed ID: 6294698
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cholecystokinin-dopamine coexistence: electrophysiological actions corresponding to cholecystokinin receptor subtype.
    Hommer DW; Stoner G; Crawley JN; Paul SM; Skirboll LR
    J Neurosci; 1986 Oct; 6(10):3039-43. PubMed ID: 3760947
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Redundant vagal mediation of the synergistic satiety effect of pancreatic glucagon and cholecystokinin in sham feeding rats.
    Le Sauter J; Geary N
    J Auton Nerv Syst; 1990 Apr; 30(1):13-22. PubMed ID: 2348051
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exogenous cholecystokinin-8 reduces vagal efferent nerve activity in rats through CCK(A) receptors.
    Bucinskaite V; Kurosawa M; Lundeberg T
    Br J Pharmacol; 2000 Apr; 129(8):1649-54. PubMed ID: 10780970
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nucleus tractus solitarius lesions block the behavioral actions of cholecystokinin.
    Crawley JN; Schwaber JS
    Peptides; 1983; 4(5):743-7. PubMed ID: 6318204
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of brain stem cholecystokinin-8s on gastric tone and esophageal-gastric reflex.
    Holmes GM; Tong M; Travagli RA
    Am J Physiol Gastrointest Liver Physiol; 2009 Mar; 296(3):G621-31. PubMed ID: 19136379
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunohistochemical studies on cholecystokinin (CCK)-immunoreactive neurons in the rat using sequence specific antisera and with special reference to the caudate nucleus and primary sensory neurons.
    Hökfelt T; Herrera-Marschitz M; Seroogy K; Ju G; Staines WA; Holets V; Schalling M; Ungerstedt U; Post C; Rehfeld JF
    J Chem Neuroanat; 1988; 1(1):11-51. PubMed ID: 3077312
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endogenous cholecystokinin stimulates pancreatic enzyme secretion via vagal afferent pathway in rats.
    Li Y; Owyang C
    Gastroenterology; 1994 Aug; 107(2):525-31. PubMed ID: 8039628
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sensitivity of vagal mucosal afferents to cholecystokinin and its role in afferent signal transduction in the rat.
    Richards W; Hillsley K; Eastwood C; Grundy D
    J Physiol; 1996 Dec; 497 ( Pt 2)(Pt 2):473-81. PubMed ID: 8961188
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Central leptin and cholecystokinin in gastroprotection against ethanol-induced damage.
    Brzozowski T; Konturek PC; Konturek SJ; Pierzchalski P; Bielanski W; Pajdo R; Drozdowicz D; Kwiecień S; Hahn EG
    Digestion; 2000; 62(2-3):126-42. PubMed ID: 11025360
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Abolition of the behavioral effects of cholecystokinin following bilateral radiofrequency lesions of the parvocellular subdivision of the nucleus tractus solitarius.
    Crawley JN; Schwaber JS
    Brain Res; 1984 Mar; 295(2):289-99. PubMed ID: 6713189
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The vagal afferent pathway does not play a major role in the induction of satiety by intestinal fatty acid in rats.
    Ogawa N; Yamaguchi H; Shimbara T; Toshinai K; Kakutani M; Yonemori F; Nakazato M
    Neurosci Lett; 2008 Mar; 433(1):38-42. PubMed ID: 18248897
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neurochemical investigation of the afferent pathway from the vagus nerve to the nucleus tractus solitarius in mediating the "satiety syndrome" induced by systemic cholecystokinin.
    Crawley JN
    Peptides; 1985; 6 Suppl 1():133-7. PubMed ID: 4047976
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of vagotomy on cholecystokinin- and dexfenfluramine-induced Fos-like immunoreactivity in the rat brain.
    Li BH; Rowland NE
    Brain Res Bull; 1995; 37(6):589-93. PubMed ID: 7670882
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Electrophysiological effects of cholecystokinin octapeptide on identified rat nigrostriatal dopaminergic neurons.
    Freeman AS; Chiodo LA
    Brain Res; 1988 Jan; 439(1-2):266-74. PubMed ID: 3359189
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Abdominal vagotomy blocks the satiety effect of cholecystokinin in the rat.
    Smith GP; Jerome C; Cushin BJ; Eterno R; Simansky KJ
    Science; 1981 Aug; 213(4511):1036-7. PubMed ID: 7268408
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.